OpenEvidence
A medical evidence search platform for physicians that provides cited clinical decision support based on peer-reviewed literature and serves numerous hospitals and doctors across the United States.
Timeline (last 90 days)
The study is being conducted by Apple in collaboration with clinical AI platform OpenEvidence.
OpenEvidence is a clinical AI platform for medical professionals that generates answers based on medical literature.
OpenEvidence mainly serves professional users such as doctors, and its answers must be verifiable.
OpenEvidence once unexpectedly went viral on TikTok, gaining about two million views in a week, during which the Vercel platform maintained low error rates and fast responses without requiring additional capacity configuration.
OpenEvidence vice president of engineering Micah Smith said that after enabling Vercel Fluid compute, server-side costs were reduced by 90% while maintaining equivalent performance.
Micah Smith said that even if scale grows 100-fold, Vercel would account for less than 5% of OpenEvidence's overall infrastructure spending.
OpenEvidence launched a patient-facing app called Take Home, which allows doctors to convert clinical answers into plain language and share them with patients; patients can view and save the evidence after logging in, and clinical trial matching is also among the planned directions for this app.
OpenEvidence provides doctors with a medical evidence search service based on peer-reviewed literature, covering more than 10,000 hospitals and medical centers across the United States and serving about 650,000 doctors.
According to official OpenEvidence information, the platform supported more than 20 million clinical consultations in January 2026.
According to official OpenEvidence information, more than 100 million U.S. patients received care from doctors using OpenEvidence in 2025.
4 more timeline events
All Facts (12)
OpenEvidence mainly serves professional users such as doctors, and its answers must be verifiable.
50%UnverifiedOpenEvidence is a clinical AI platform for medical professionals that generates answers based on medical literature.
50%UnverifiedThe study is being conducted by Apple in collaboration with clinical AI platform OpenEvidence.
50%UnverifiedOpenEvidence launched a patient-facing app called Take Home, which allows doctors to convert clinical answers into plain language and share them with patients; patients can view and save the evidence after logging in, and clinical trial matching is also among the planned directions for this app.
50%UnverifiedOpenEvidence provides doctors with a medical evidence search service based on peer-reviewed literature, covering more than 10,000 hospitals and medical centers across the United States and serving about 650,000 doctors.
50%UnverifiedAccording to official OpenEvidence information, more than 100 million U.S. patients received care from doctors using OpenEvidence in 2025.
50%UnverifiedIn medical scenarios, software needs to be stable, fast, and trustworthy; the OpenEvidence team requires a simple deployment process, rapid rollback, and reliable performance, because its tools are directly tied to clinical decisions.
50%UnverifiedOpenEvidence deploys each app as an independent Vercel project bound to a custom domain, so that a single release affects only the corresponding app, with the fault domain and rollback scope confined to a single product.
50%UnverifiedOpenEvidence's doctor-facing web app is built on the Next.js framework and deployed on the Vercel platform, using preview deployment and production deployment workflows.
50%UnverifiedOpenEvidence vice president of engineering Micah Smith said that after enabling Vercel Fluid compute, server-side costs were reduced by 90% while maintaining equivalent performance.
50%UnverifiedMicah Smith said that even if scale grows 100-fold, Vercel would account for less than 5% of OpenEvidence's overall infrastructure spending.
50%UnverifiedOpenEvidence once unexpectedly went viral on TikTok, gaining about two million views in a week, during which the Vercel platform maintained low error rates and fast responses without requiring additional capacity configuration.
50%